Provided by Tiger Trade Technology Pte. Ltd.

Zai Lab Ltd

24.17
-0.9100-3.63%
Post-market: 23.85-0.3200-1.32%16:39 EDT
Volume:1.61M
Turnover:39.03M
Market Cap:2.72B
PE:-14.19
High:24.66
Open:24.01
Low:23.64
Close:25.08
52wk High:34.72
52wk Low:15.96
Shares:112.35M
Float Shares:97.11M
Volume Ratio:2.20
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7030
EPS(LYR):-1.6026
ROE:-26.91%
ROA:-14.75%
PB:4.47
PE(LYR):-15.08

Loading ...

Jefferies Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Apr 23

Press Release: Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026

Dow Jones
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Passage Bio (PASG), Climb Bio (CLYM) and Zai Lab (ZLAB)

TIPRANKS
·
Apr 21

Zai Lab Shares Climb Over 5% on Positive Preclinical Data for ZL-1503

Stock News
·
Apr 20

Zai Lab presents new preclinical data on ZL-1503

TIPRANKS
·
Apr 20

Zai Lab to Present Zoci Data From Ongoing Phase 1 Trial at AACR Annual Meeting

MT Newswires Live
·
Apr 18

Zai Lab to present zocilurtatug pelitecan clinical data at AACR meeting

TIPRANKS
·
Apr 18

Guotai Haitong Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)

TIPRANKS
·
Apr 16

Zai Lab Shares Climb Over 4% on Partnership with Boehringer Ingelheim for Novel Dual DLL3-Targeting Combination Therapy

Stock News
·
Apr 16

Asian Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Apr 15

Zai Lab Shares Climb Over 3% Following Global Clinical Partnership with Amgen for Zoci Candidate

Stock News
·
Apr 14

Zai Lab Ltd (1ZLB) Receives a Buy from CICC

TIPRANKS
·
Apr 11

Amgen-Backed DLL3 Combo Trial Could Be A Game Changer For Zai Lab (ZLAB)

Simply Wall St.
·
Apr 11

Zai Lab Grants Stock Options, Restricted Share Units, and Performance Share Units

Stock News
·
Apr 02

Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen

Deep News
·
Apr 02

Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment

Stock News
·
Apr 02

Asian Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

MT Newswires Live
·
Apr 01

Zai Lab Reports Fiscal Year Results with 15% Revenue Growth to $460 Million and Positive Pipeline Updates

Stock News
·
Mar 27

J.P. Morgan Sticks to Its Buy Rating for Zai Lab (ZLAB)

TIPRANKS
·
Mar 26

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 26